Rapalogix Health Recognized for Science-First Platform with Judges’ Choice Award at Octane Aesthetics Tech Forum

January 21, 2026

New York, New York, January 26, 2026— Rapalogix Health, a biotechnology company advancing a science-first approach to cellular longevity and skin health, announced today that it received the Judges’ Choice Award at Octane’s 7th Annual Aesthetics Tech Forum: Forging the Future of Aesthetics.

The award was presented during Octane’s Capital & Growth Company Presentations, a competitive pitch forum recognizing companies with platforms built for long-term clinical relevance. This year’s judging emphasized durability as the true measure of innovation quality, highlighting biology-driven approaches with clear paths to real-world translation. Rapalogix Health was selected for its science-first platform focused on restoring cellular balance as the foundation for lifelong skin health. Judges cited the company’s durable biological rationale, well-defined mechanism of action, and strong translational potential as key differentiators.

“Presenting at Octane’s Aesthetics Tech Forum was an incredible experience,” said Rahul Mehta, Chief Executive Officer and Co-Founder of Rapalogix Health. “Our team is deeply committed to tackling skin aging at its biological roots, and it’s rewarding to see that approach resonate with the judges. This award reflects our belief that durability and long-term relevance matter just as much as innovation.”

Rapalogix CEO Rahul Mehta, PhD., accepting award

About Rapalogix Health
Rapalogix Health is a New York-based biotechnology company pioneering the next evolution in skin health. Rapalogix translates foundational insights in longevity science into transformative dermatological solutions. Grounded in a science-first approach, the company is developing an innovative pipeline of prescription therapeutics and professional skincare products. Re-Q Pro-longevity Face Serum, the first product from Rapalogix’s professional skincare brand, Re-Q Health, is now available at select dermatology practices in the United States. Re-Q Pro-Longevity Face Serum is powered by RLX-201, Rapalogix’s proprietary pro-longevity molecule designed to reset and restore exhausted skin cells, extend their longevity, and deliver healthy and youthful skin over a lifetime.

For more information on Rapalogix Health, visit www.rapalogix.com or follow Rapalogix on LinkedIn and Instagram.

For more information on Re-Q Health, visit www.reqhealth.com or follow Re-Q Health on Instagram.


About Octane
Octane convenes and enables the Southern California tech and medtech business ecosystem by connecting people, resources, and capital. We impact our community through LaunchPad, a top-performing accelerator, and Capital & Growth, a platform to provide companies with capital and growth resources. In addition, Octane hosts dozens of programs throughout the year and has direct access to capital and partners. Learn more at octaneoc.org